Table 1.
Baseline characteristics of patients and divided by reduction in hs-CRP levels.
| Characteristics | Total (n = 3924) | No reduction in hs-CRP levels (n = 2320) | Reduction in hs-CRP levels (n = 1604) | P |
|---|---|---|---|---|
| Age (year) | 54.9 ± 10.8 | 56.9 ± 10.4 | 52.2 ± 10.8 | <0.001 |
| Male | 3013 (76.8) | 1702 (73.4) | 1311 (81.7) | <0.001 |
| SBP (mmHg) | 137.0 ± 21.6 | 139.3 ± 21.7 | 133.8 ± 21.2 | <0.001 |
| BMI (kg/m2) | 26.5 ± 3.7 | 26.7 ± 3.8 | 26.1 ± 3.5 | <0.001 |
| Waist circumference (cm) | 91.6 ± 10.1 | 93.2 ± 9.8 | 89.2 ± 9.9 | <0.001 |
| FBG (mmol/L) | 6.3 (5.9, 7.6) | 6.4 (5.9, 7.8) | 6.2 (5.8, 7.4) | <0.001 |
| TC (mmol/L) | 5.1 (4.5, 5.8) | 5.1 (4.5, 5.9) | 5.1 (4.4, 5.7) | 0.10 |
| TG (mmol/L) | 1.6 (1.1, 2.5) | 1.7 (1.2, 2.6) | 1.5 (1.0, 2.3) | <0.001 |
| LDL-C (mmol/L) | 2.3 (1.4, 3.0) | 2.1 (0.7, 2.9) | 2.5 (2.0, 3.0) | <0.001 |
| HDL-C (mmol/L) | 1.5 (1.3, 1.8) | 1.5 (1.3, 1.8) | 1.5 (1.3, 1.7) | <0.001 |
| Uric acid (μmol/L) | 289.6 ± 90.0 | 285.0 ± 92.4 | 296.4 ± 85.9 | <0.001 |
| eGFR (mL/min/1.73m2) | 83.6 ± 32.6 | 84.1 ± 37.7 | 82.9 ± 23.1 | <0.001 |
| Baseline hs-CRP (mg/L) | 6.0 (4.0, 9.2) | 6.63 (4.4, 9.65) | 5.0 (3.7, 8.3) | <0.001 |
| Proteinuria (N (%)) | 681 (18.1) | 425 (18.8) | 256 (17.3) | <0.001 |
| Cigarette use (N (%)) | 1139 (31.4) | 557 (26.9) | 582 (37.2) | <0.001 |
| Drinker (N (%)) | 1251 (34.5) | 588 (28.5) | 663 (42.5) | <0.001 |
| Physical exercise (N (%)) | 615 (17.1) | 330 (16.1) | 285 (18.3) | 0.09 |
| Hypertension (N (%)) | 2295 (58.5) | 1472 (63.5) | 823 (51.3) | <0.001 |
| Diabetes (N (%)) | 1465 (37.3) | 915 (39.4) | 550 (34.3) | <0.001 |
| Hypotensive drugs (N (%)) | 692 (34.2) | 412 (32.6) | 280 (36.8) | 0.052 |
Note: SBP = systolic blood pressure; BMI = body mass index; FBG = fasting blood glucose; TC = total cholesterol; TG = triglyceride; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density lipoprotein cholesterol; eGFR = estimated glomerular filtration rate.